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Objectives: This study reports the results of a prospective continuous cohort of patients treated for endovascular
aneurysm repair (EVAR) with a unified anesthetic strategy based on the use of local anesthesia (LA) in all patients,
while reserving regional (RA) or general anesthesia (GA) only for those with predefined individually or surgically
specific indications.
Methods: All patients treated by EVAR for an elective aortic abdominal aneurysm (AAA) between April 1998 and
December 2003 were included. The strategy of treatment generated three cohorts of patients (LA, RA, or GA).
Primary outcome included all-cause mortality, nonfatal cardiac morbidity, respiratory complications, and renal
failure. Secondary outcome measures included conversion to general anesthesia, use of analgesics, and time-related
outcomes (operating time, length of stay in intensive care unit and hospital, time required to resume oral intake, and
time to ambulation).
Results: A total of 239 patients underwent EVAR: 170 LA, 31 RA, and 38 GA. Overall mortality was one patient
(0.4%). LA was associated with a lower incidence of complications compared with GA (P < .001). In the LA group,
two patients had to be converted to GA, one because of a dissection and one because of anxiety. In 13% of the
patients in the LA group, additional intravenous sedation or analgesia was required. Operating time and length of
stay in intensive care was shorter in the LA and RA groups than in the GA group (P < .001). Length of stay in
hospital and time to ambulation and regular diet was shorter in the LA group compared with the RA and GA groups
(P < .001).
Conclusions: A strategy based on the preferential use of LA for EVAR restricting RA or GA only to those with predefined
contraindications is feasible and appears to be well tolerated. (J Vasc Surg 2005;42:402-9.)In all fields of surgery developments have occurred in
the direction of minimally invasive techniques to reduce
mortality, morbidity, and discomfort to patients. In vascu-
lar surgery, this direction has been embodied by the tech-
nique of endovascular aneurysm repair (EVAR).
Patients undergoing aortic surgery have a higher than
average risk of perioperative cardiac mortality and morbid-
ity than patients undergoing nonvascular surgery.1,2 Phys-
iologic factors associatedwith this increased incidence of com-
plications include hemodynamic andmetabolic changes, fluid
shift and blood loss, increased myocardial oxygen demand
secondary to stress from surgery and anesthesia, increase in
postoperative platelet reactivity, and prolonged anesthetic
time.3,4 EVAR is performed with minimally invasive tech-
niques and is associated with reduced blood loss and in-
creased hemodynamic stability.5,6 Two randomized, con-
trolled trials have shown that EVAR is associated with
reduced mortality and morbidity compared with open
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doi:10.1016/j.jvs.2005.05.047techniques.7,8 Traditionally, however, EVAR is still per-
formed under regional (RA) or general (GA) anesthesia.
Since mortality, postoperative complications, and length of
stay are the consequences of surgical and anesthetic tech-
niques, a change in the latter may contribute to reduce
morbidity and costs after EVAR.
Feasibility and small cohort studies reported encour-
aging results using local anesthesia (LA) in this set-
ting.9-11 Other authors, however, found no difference in
cardiac mortality and morbidity in a retrospective cohort
of patients receiving LA or GA.12 To our knowledge,
there are no randomized, controlled trials or large pro-
spective cohort studies documenting the role of LA in
EVAR.
The aim of this work was to report the results of a
prospective continuous cohort of patients treated by
EVAR in a tertiary vascular referral center with a unified
anesthetic strategy. This was based on the use of LA
in all patients, while reserving RA or GA only for
those with predefined individually or surgically specific
indications.
MATERIALS AND METHODS
Type of study
This was a prospective cohort study of 239 consecu-
tive elective patients treated with EVAR between April
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center by a single endovascular team. To define the
overall pool of patients undergoing abdominal aortic
aneurysm (AAA) surgery during the same period, data
regarding open repairs were collected retrospectively
from hospital records.
Inclusion criteria
Surgery was indicated for aneurysms greater than 5
cm in diameter. An aortic aneurysm greater than 4 cm
was also an indication for surgery if associated with iliac
artery aneurysms greater than 3.5 cm. EVAR was sug-
gested as a treatment option to all patients, and indica-
tions were based on anatomic considerations and pa-
tient’s preference.
From April 1998, a unified strategy to treat all elective
patients undergoing EVAR under LA was adopted. Abso-
lute exclusion criteria were need for additional retroperito-
neal approach to the aorta or iliac arteries, need for associ-
ated abdominal procedures (eg, umbilical hernia repair),
and patient’s choice. Relative exclusion criteria were anxi-
ety, groin re-explorations, and body mass index (BMI)
30 kg/m2 (obese patients). If LA was contraindicated,
the choice between RA and GA was left to the patients’ and
anesthesiologists’ preference.
During the study period, 40 patients underwent EVAR
on an emergency basis. The results pertinent to these
patients are reported for completeness but excluded from
the main analysis.
Techniques
Surgery. All patients received a detailed explanation of
EVAR under local anesthesia before surgery, and the study
was approved by the hospital review board. EVAR was
always conducted in an operating room.
Perioperative measures. Cefuroxime was adminis-
tered intravenously (IV) for antibiotic prophylaxis in the
operating room. A peripheral 14- or 16-gauge venous
cannula was inserted in all patients for fluid administration.
For RA and GA, electrocardiographic monitoring, pulse
oximetry, end-tidal CO2 (maintained at 4-5%) and urine
output were recorded. In patients undergoing GA, a 20-
gauge radial arterial line and a 14-gauge double-lumen
central venous cannula were also used for arterial and
central venous pressure monitoring, blood sampling, and
fluid administration; in these patients, a pulmonary artery
catheter was used selectively in the presence of severe left
ventricular dysfunction or pronounced pulmonary hyper-
tension. Invasive monitoring was rarely used for RA and
never for LA. During all locoregional procedures, supple-
mental oxygen was given.
Local anesthesia. LA was achieved using infiltration
with lidocaine 1% (maximum safe dose 4 mg/kg) or
bupivacaine 0.5% (maximum safe dose 2 mg/kg) with
epinephrine. Intravenous sedation was used occasionally
to maximize comfort rather than to provide analgesia.The goal was to maintain patients fully awake, coopera-
tive, and capable of controlling their airways. Pain was
treated, when necessary, with fentanyl, 50-150 g IV
bolus or occasionally with remifentanil 0.1 g/kg/min
continuous infusion. In restless or anxious patients, mi-
dazolam 0.05-0.2 mg/kg IV or propofol 25-75 g/kg/
min IV were used. Operative monitoring included con-
tinuous electrocardiography, pulse oxymetry, and
arterial blood pressure measured with automatic inter-
mittent plethysmography. A central venous line and a
Foley catheter were used earlier in the series. With
increasing confidence in the technique and shortened
operating time, this practice was stopped. The anesthe-
tist and a nurse with specific training noted signs and
symptoms of pain, maintained verbal communication,
and kept patients informed about the progress of
surgery.
The technique of local anesthesia and femoral artery
dissection were tailored to maximize patient tolerance.
After abdomen and groins were prepped and draped per
routine open repair, the position of the inguinal ligament
was traced with a skin marker. A 5-cm line was drawn
intersecting the inguinal ligament at the level of the femoral
artery (2 cm above and 3 cm below). The dermis and
subcutaneous fat were first infiltrated bilaterally with the
local anesthetic agent, and sharp dissection (without use of
diathermy) was carried out only in one groin and to the
level of Scarpa’s fascia. At this point, local anesthetic was
infiltrated under this fascia and dissection was stopped and
continued in the contralateral groin where the process was
repeated. The attention was then returned to the groin
dissected first. When the femoral artery was identified, a
small amount of local anesthetic was injected in the fascia
around the artery and a 3-cm segment was controlled with
vessel loops. The procedure was then repeated in the con-
tralateral groin.
To minimize ischemic rest pain caused by occluding
the femoral artery due to clamping and/or prolonged
insertion of the introduction device, the following tech-
nique of access was used. In the anterior wall of each
common femoral artery, two concentric purse-string su-
tures of 5 to 6 mm in diameter were applied using 4-0
polypropylene. The purse-strings were controlled with
Rummel’s tourniquets (Fig 1). Catheter access and de-
vice insertions were done through the purse-string su-
tures previously applied without clamping the femoral
arteries. To avoid discomfort to the patient during inser-
tion of the main delivery sheath, this was advanced slowly
in the arterial system. To accurately deploy the stent graft
close to the renal arteries, intraoperative angiography
was used. Angiography, however, was done only after the
main delivery sheath had been advanced to the level of
the first lumbar vertebra. This technique avoided arti-
facts caused by patient movements during insertion of
the device, which may be uncomfortable due to stretch-
ing of the iliac artery. As soon as possible, the empty
sheath of the main device was removed (ie, after full
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strings tightened with the Rummel’s tourniquet around
the guidewire. This was left in place until the contralat-
eral limb of the stent graft was delivered and a comple-
tion angiogram obtained. Temporary closure of the fem-
oral access around the guidewire achieved the effect of
restoring normal blood flow to the limb but allowed
reaccess of the artery if this became necessary. At the end
of the procedure, the artery was repaired by simply
tightening the purse-string sutures without the need for
arterial repair. Before closure of the incision, local anes-
thetic was infiltrated again in both groins. After surgery,
patients were cared for in recovery and then transferred
to the ward where normal diet and activity was resumed.
The urinary catheter, if present, was removed on the day
of surgery.
Definition of outcomes
The aneurysm morphology and angulations were clas-
sified according to the standards suggested by the Society
for Vascular Surgery.13
In the postoperative period, cardiac and respiratory
investigations were only undertaken if patients became
clinically symptomatic. An electrocardiogram or cardiac
enzymes were not systematically obtained in all patients.
Nonfatal cardiac complications were therefore only those
that became clinically apparent: precordial pain, symptoms
and signs of pulmonary congestion, ventricular failure, and
the need for diuretic agents. Because of the anticipated low
event rate, as a primary outcome we chose a composite
outcome including the following cluster: all-cause mortal-
ity, nonfatal cardiac morbidity, respiratory complications,
Fig 1. Technique of femoral access with purse-string sutures and
Rummel’s tourniquets in the common femoral artery.and renal failure. Renal failure was defined as need fortemporary or chronic dialysis or a greater than 40% increase
in preoperative creatinine.14 Respiratory complications
were defined as the occurrence of pneumonia, respiratory
failure requiring pharmacologic intervention, or ventilatory
support.
Secondary outcomes included additional clinical out-
comes (conversion to general anesthesia, wound complica-
tions, urinary retention); pre-, intra-, and postoperative use
of analgesia; pre- and postoperative hemoglobin and blood
product use; time-related outcomes (fluoroscopy time,
contrast volume used, operating time, length of stay in
recovery room or intensive care unit, time required to
resume oral intake, time to ambulation, and length of stay
in hospital).
Wound complications were classified as minor if they
were superficial and did not require débridement.15
Statistical analysis
Data were prospectively collected in an Excel spread
sheet (Microsoft Corporation). A summary of continuous
variables are expressed as mean SD. Categorical variables
were analyzed with Pearson 2 test, and continuous vari-
ables were analyzed with Student’s t test (normal distribu-
tion) or Mann-Whitney U test (skewed distribution). Dif-
ferences between groups with more than two factors were
analyzed with the Kruskal-Wallis test. To analyze known
and unknown variables that affect outcomes over time for
types of anesthesia, the Cuzick test was used because it is
more powerful than the Wilcoxon rank-sum to detect dif-
ferences between more than two groups of data.16 All the
analyses were two tailed and P  .05 was considered
statistically significant. Data were analyzed using SPSS 11.0
(SPSS, Chicago, Ill) and Arcus Quickstat, Biomedical ver-
sion 1.0.
Patients requiring interventions other than aneurysm
repair (eg, umbilical hernia) or retroperitoneal approach for
access were excluded (eight in the GA group, two in the RA
group, and one in the LA group) from the comparison of
time-related outcomes (operating time, stay in recovery or
hospital, resumption of oral intake and ambulation, post-
operative analgesia).
RESULTS
The demographics, comorbidities, and indications
for surgery (aneurysm size) in patients undergoing
EVAR and open AAA repair are summarized in Table I.
This shows the denominator of the overall pool of aneu-
rysms treated during the study period. The diameter of
aneurysms was smaller, women were fewer, and risk
factors (tobacco use, hypertension, cardiac and carotid
disease) less prevalent in the EVAR group compared with
the open group.
In patients undergoing endovascular aneurysm repair,
five different types of stent grafts were used and implanted
according to their instructions for use (Table II). The type
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EVARwith different anesthetic techniques (F7.8, df2;P
.02). Table III illustrates the demographics and risk factors
in these three groups. Statistically significant differences
were found for age (the GA group was younger) and
gender (females were less represented in the LA group).
The mean BMI and hyperlipidemia were significantly lower
in the LA group, but there were no differences with respect
Table I. Demographics and comorbidities of patients
undergoing abdominal aortic aneurysm repair
EVAR
(n  239)
Open AAA
repair
(n  130) P
Age, mean  SD 70  7 69  8 .13
Female sex, no. (%) 11 (5) 21 (16) .001
Body mass index, kg/m2
 SD
27  3 26  4 .07
Previous abdominal
procedures, no. (%)
37 (15) 17 (13) .6
ASA score, no. (%)
I 13 (5) 3 (2)
II 102 (43) 49 (38)
III 113 (47) 73 (56)
IV 11 (5) 5 (4)
Mean  SD 2.5  0.7 2.6  0.6 .1
SVS-ISCVS risk score,
no. (%)17
Diabetes 21 (9) 5 (4) .08
Tobacco use 116 (49) 78 (60) .04
Hypertension 113 (47) 83 (64) .003
Hyperlipidemia 92 (38) 45 (35) .4
Cardiac disease 118 (49) 81 (62) .02
Carotid disease 13 (5) 19 (15) .003
Renal disease 25 (10) 23 (18) .05
Obstructive lung
disease
68 (28) 40 (31) .7
Aneurysm size in mm,
mean  SD
58.4  9.2 62.2  13.7 .002
EVAR, Endovascular aneurysm repair; AAA, abdominal aortic aneurysm;
ASA, American Society of Anaesthesiology classification; SVS-ISCVS, Soci-
ety of Vascular Surgery–International Society of Cardiovascular Surgery,
North American Chapter.
Table II. Types of endoprostheses used
Type of anesthesia
Local no. (%) General no. (%) Regional no. (%)
Excluder* 34 (74) 6 (13) 6 (13)
Quantum† 12 (92) — 1 (8)
Talent‡ 34 (68) 7 (14) 9 (18)
Vanguard§ 17 (52) 13 (39) 3 (9)
Zenith¶ 73 (75) 12 (12) 12 (12)
Total 170 (71) 38 (16) 31 (13)
*Excluder (W. L. Gore, Flagstaff, Ariz).
†Quantum (Cordis, Johnson and Johnson, Fort Lauderdale, Fla).
‡Talent (World Medical/Medtronic Corp., Sunrise, Fla).
§Vanguard (Boston Scientific Corp., Waterston, Mass).
¶Zenith (Cook, Bloomington, Ind).to other risk factors. Table IV describes the aneurysm-related variables. There were no differences in neck angu-
lations and distribution of grade I and III aneurysms be-
tween groups, but there were fewer grade IIA and more
grade IIB aneurysms in the GA group. Table V shows the
different reasons for exclusion from LA in the RA and GA
groups.
With respect to the composite primary outcome, LA
was associated with a statistically significant lower inci-
dence of complications compared with GA (P  .001).
The difference between LA and RA and RA and GA, was
not significant (P  .054 and P  .053, respectively).
Table VI summarizes the results of the clinical outcomes.
There were more respiratory complications in the GA
group and fewer renal complications in the LA group.
Wound complications were all minor and equally distrib-
uted among the three groups. They included seromas
and hematomas that did not require intervention. In two
patients treated with LA, an additional angiogram was
required because the patient moved just before graft
deployment.
LA was used as planned in 168 of 170 patients (99%).
In one patient, early in the series, conversion to GA was
required because of an iliac dissection that occurred
during introduction of the delivery sheath. Access had to
be regained through a retroperitoneal approach. In a
second patient, conversion to GA was necessary because
of anxiety. There was no significant difference in the
number of patients treated with GA or RA (38 and 31,
respectively, P  .96), but more patients were treated
with LA (n  170) than with RA (P  .001) or GA (P 
.001), respectively. Analysis of trend showed a statistical
difference in the pattern of type of anesthesia adminis-
tered over the 6-year period (P  .003) in favor of an
increased number of LA associated with a reduction in
GA (Fig 2). The significance of this trend, however,
disappeared when the data were analyzed excluding the
first year of the study.
Premedication with benzodiazepines was used in 89%
of patients operated on with GA, 58% with RA, and 59%
with LA, respectively (P .30). During surgery IV analge-
sia or sedation was used in 13% of patients operated on with
LA. Discomfort during dissection of the groins, during
introduction of the main delivery sheath, and nausea or
anxiety was experienced by 16 (9%), 18 (11%), and 2 (3%),
respectively, of patients operated with LA. Table VII sum-
marizes the type and amount of postoperative use of anal-
gesic medications in the three groups. There was a differ-
ence in postoperative analgesia requirement in favor of the
LA group compared with the RA and GA group (P 
.001). The proportion of patients who did not require
analgesic agents postoperatively was highest in the LA
group (difference with GA, P  .001; difference with RA,
P  .002).
Transfusion of blood products was not required in
any patient undergoing EVAR. Fluoroscopy time was
greater in the GA group (27.1  19.8 minutes) com-
pared with the RA (10.9  8.8 minutes, P  .001), and
the LA (11.0  10.2 minutes, P  .001) groups. Simi-
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in the GA group (187  76 ml) compared with the RA
(143  48 ml, P  .008), and LA (148  49 ml, P 
.001) groups. Operating time including anesthesia time,
and length of stay in intensive care, were significantly
shorter in the LA and RA group compared with the GA
group. Length of stay in the hospital and in the recovery
room and time to ambulation and regular diet were
significantly shorter in the LA group compared with the
GA and RA groups (Table VIII, online only).
A total of 40 emergency aneurysms (25 acute ruptured,
Table III. Demographics of patients undergoing EVAR s
Local
(n  170)
Age, mean  SD 70.7  7.3
Female sex, no. (%) 3 (2)
Body Mass Index, kg/m2 26.0  3.2
Previous abdominal procedures, no. (%) 23 (14)
ASA score, no. (%)
I 9 (5) 
II 71 (42)
III 83 (49) 
IV 7 (4)
Mean  SD 2.5  0.7
SVS-ISCVS risk score, no. (%)17
Diabetes 14 (8)
Tobacco use 76 (45)
Hypertension 75 (44)
Hyperlipidemia 55 (33)
Cardiac disease 87 (51)
Carotid disease 8 (5)
Renal disease 16 (9%)
Obstructive lung disease 50 (29%)
Creatinine, mean  SD (mmol/L) 110  22
EVAR, Endovascular aneurysm repair;ASA, American Society of Anaesthesi
of Cardiovascular Surgery, North American Chapter.
Table IV. Anatomic characteristics of aneurysms treated
with EVAR
Classification*13
Type of anesthesia
P
Local
(n  170)
General
(n  38)
Regional
(n  31)
Aneurysm size in mm,
mean  SD
58  9 59  12 58  8 .9
Grade I, no. (%) 13 (8) 1 (3) 1 (3) .4
Grade IIA, no. (%) 110 (65) 14 (37) 21 (68) .01
Grade IIB, no. (%) 38 (22) 19 (50) 7 (23) .01
Grade III, no. (%) 7 (4) 4 (11) 1 (3) .2
Grade IV, no. (%) 2 (1) 0 1 (3) .5
Tortuosity of the
aorta, no. (%)
180-150 degrees 151 (89) 28 (74) 26 (84) .06
150-120 degrees 16 (9) 10 (26) 5 (16) .08
120 degrees 3 (2) 0 0 .5
*Society of Vascular Surgery–International Society of Cardiovascular Sur-
gery, North American Chapter.15 acute nonruptured) were treated with EVAR (11% ofthe entire population of aneurysms treated during the study
period). In this group, EVAR was completed with LA in 33
patients (83%), and survival was 88%.18,19
DISCUSSION
In this study, 70% of elective aneurysms were treated
with an endovascular repair and 70% of these were oper-
ated on with LA. RA or GA were reserved only for selected
patients. Two patients in the LA group (1%) were con-
verted to GA, one because of an intraoperative complica-
tion and one because of anxiety.
Patients undergoing open repair had a greater num-
ber of risk factors compared with those undergoing
EVAR. There was, however, no difference with respect
the American Society of Anesthesiology (ASA) classifica-
tion. These findings may be explained by the high-risk
ed according to the type of anesthesia
Type of anesthesia
P
General
(n  38)
Regional
(n  31)
66.7  7.9 70.8  6.3 .02
4 (11) 4 (13) .004
28.0  3.4 28.5  2.7 .001
7 (18) 7 (23) .4
3 (8) 1 (3)
16 (42) 15 (48)
15 (40) 15 (48)
4 (11) 0
2.5  0.8 2.5  0.6 .9
6 (16) 1 (3) .2
21 (55) 19 (61) .2
20 (53) 18 (58) .3
21 (55) 16 (52) .01
15 (39) 16 (52) .4
4 (11) 1 (3) .3
5 (13%) 4 (13) .7
7 (18%) 11 (35%) .3
110  27 111  32 .7
classification; SVS-ISCVS, Society of Vascular Surgery–International Society
Table V. Reasons for exclusion from local anesthesia
Type of anesthesia
General
(n  38)
Regional
(n  31)
Patient’s choice 14 15
Body mass index 30 kg/m2 11 14
Technical reasons
Additional procedure 3* 2†
Retroperitoneal approach 5 0
Previous groin surgery 5 0
*Two umbilical hernias, one iliofemoral crossover bypass.
†Profundaplasty.tratifi
ologypatients referred to our center (Table II) and by the
(4)
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risk and cardiac complications.2,20 There were fewer
women in the EVAR group, reflecting gender differences
in anatomic suitability for endovascular repair, including
arterial access. The size of aneurysms operated in the
open group was also larger than in the EVAR group. This
may be explained by the fact that larger aneurysms have
also other anatomic characteristics (eg, short, conical, or
angulated necks), which renders them unsuitable for
endovascular surgery.21
The anesthetic strategy used in this study generated
three distinct groups of patients through the inclusion and
exclusion criteria process. These three groups are not di-
rectly comparable. There was a difference with respect to
the type of grafts used. This reflected the availability of
endoprostheses over time rather than an effect of the grafts
on the ability to use LA. Risk factors and anatomic charac-
teristics of the aneurysms were similarly distributed among
patients receiving EVAR with different anesthetic tech-
niques (LA, RA, GA), except for hyperlipidemia and BMI,
which were more represented in the GA and RA groups.
Those in the GA group were also younger and exhibited a
higher incidence of preoperative renal failure. Although
this difference did not reach statistical significance, it may
explain why renal failure was more prevalent in these pa-
tients. The combined incidence of mortality, nonfatal car-
Table VI. Clinical outcomes
Lo
(n 
All cause mortality, no. (%)
Cardiac mortality, no. (%)
Non-fatal cardiac morbidity, no. (%) 2
Respiratory complications, no. (%)
Renal failure, no. (%)
Preoperative creatinine (mmol/L), mean  SD 110
Postoperative creatinine (mmol/L), mean  SD 108
Wound complications, no. (%) 12
Urinary retention, no. (%) 6
Fig 2. Distribution of types of anesthesia over time.diac morbidity, respiratory complications, and renal failurewas lower in the LA group compared with the GA group.
Overall mortality for EVAR, however, was 0.4%, in keeping
with the results of randomized, controlled trials and not
different in the three groups.7,8
Patients operated on with GA spent significantly
longer time in the operating room, in the recovery room,
and in the hospital compared with those operated on
with LA and RA. Since we have excluded from this
analysis those patients who received adjunctive proce-
dures (eg, retroperitoneal exposure, repair of umbilical
hernia), these differences are plausible. Blood losses,
volume of ionized contrast, and exposure to radiation
were also greater in the GA than in the LA and RA
groups. The reasons for these differences are unclear:
random events, greater complexity of patients operated
on with GA, type of endoprosthesis used, or a more
relaxed approach to surgery when patients are operated
on under GA are among the possible explanations. The
use of postoperative analgesia was reduced in the LA
group compared with the other two groups. This may be
attributed to a prolonged beneficial effect on pain caused
by the infiltration of local anesthesia or to a difference in
the technique of dissection when patients are operated
on with LA.
Patients operated with LA could often be discharged
on the first postoperative day. However, in our institution,
the policy was to discharge patients treated with EVAR only
after a computed tomography scan of the abdomen. This
contributed to an average hospital stay (including a preop-
erative admission day) for these patients of 3.6 days. At
present, however, all patients, regardless the type of anes-
thesia, are routinely discharged on day 1, except if compli-
cations occur.
The use of LA in EVAR was described in small, non-
consecutive feasibility studies.9-11 Aadahl et al22 reported a
cohort study of 21 patients treated with EVAR under spinal
anesthesia with one postoperative mortality, one myocar-
dial infarction, and one case of pneumonia. De Virgilio et
al12 reported a retrospective study of 71 patients treated
with LA compared with 158 patients treated with GA. No
differences in cardiopulmonary complications were identi-
Type of anesthesia
P
General
(n  38)
Regional
(n  31)
1 (3) 0 .07
1 (3) 0 .07
1 (3) 1 (3) .6
5 (13) 0 .001
2 (5) 1 (3) .02
110  27 111  32 .7
111  36 122  68 .9
2 (5) 6 (19) .06
2 (5) 2 (6) .7cal
170)
0
0
(1)
0
0
 22
 26
(7)fied between the LA group (19%, 95% confidence interval:
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8-20%). Patients in the LA group were older and had a
greater number of risk factors. The interpretation of this
study is, however, limited by the retrospective design, the
difference in risk factors between the two groups, and
because the criteria used to choose LA and GA were not
defined a priori.
Our findings suggest that local anesthesia is feasible and
offers advantages in patients who are not obese, do not
require additional procedures, had no previous surgery in
the inguinal region, and undergo standard EVAR. A po-
tential advantage of LA is also the fact that overstretching
the arterial system by the delivery sheath induces discom-
fort, which alerts the physician of the risk of injury or
rupture.
The inference drawn from our results is strengthened
by the prospective design, the unified strategy used, and the
large number of patients included. Biases are, however,
inherent to cohort studies of this type, and the direction is
often unpredictable. This is demonstrated by the fact that
in spite of predefined criteria for the use of different types of
anesthesia, fewer patients received LA during the first year
of the study.
We believe that detailed information and preparation of
the patient, careful dissection, slow insertion of the main
delivery sheath, early restoration of blood flow to the lower
extremities, and a short operating time (usually within 2
hours) are necessary to achieve good results with LA.
CONCLUSIONS
This study demonstrated that in tertiary centers with
extensive experience in EVAR, LA is well tolerated in most
patients and is associated with few systemic complications,
a short operating time, and recovery from surgery.
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Type of anesthesia
P
Local
(n 169)*
General
(n  30)*
Regional
(n  29)*
Operating room time, min 109  30 139  48 100  20 .001
Length of stay
Intensive care unit, min 0 1316 (n  2) 0 .001
Recovery, min 96  103 234  288 160  199 .001
Hospital,† d 3.6  3.4 5.4  3.3 5.2  8.4 .001
Time to ambulation, d 1.0  0.3 2.1  2.2 1.4  1.3 .001
Time to regular diet, d 0.4  0.6 2.1  2.3 1.0  0.9 .001
*Excluded patients because of additional abdominal procedures: one in the LA group; eight in the GA group, and two in the RA group.
†Including preoperative admission day.General anesthesia
GA was administered according to the local, standard
guideline. Anesthesia was induced with fentanyl 0.7 – 2.0
g/kg or sufentanil 0.2 – 0.6 g/kg , followed by three
minutes of preoxygenation and administration of etomi-
date 0.1 – 0.4 mg/kg. After loss of the lash reflex, patients
were ventilated by mask with 100% O2, and rocuronium in
an intubation dose of 0.6 mg/kg was injected. As required,
small maintenance doses of etomidate were given, or the
patient was ventilated with isoflurane. Anesthesia was main-
tained with fentanyl, rocuronium and an oxygen - isoflu-
rane mixture. The central venous pressure was kept be-
tween 6 and 10 mmHg infusing Ringer’s lactate or normal
saline. Hydroxyethylstarch (HAES - Steril®6%, Fresenius
Kabi, Germany) was used as a plasma expander. Hyperten-
sion was treated with fentanyl and/or beta-adrenergic
blockers. If beta-adrenergic blockers were contra-indicated
continuous infusion with nitroglycerine was started. Hypo-
tension was treated, according to its cause, with fluid ad-
ministration and/or vaso-active drugs like intravenous
ephedrine or phenylephrine. Patients were kept normo-thermic with heated intravenous fluids and with a convec-
tive air warming system (WarmTouch®, Mallinckrodt,
USA). Immediately after the operative procedure patients
were extubated.
Lumbar spinal or epidural anesthesia
Lumbar spinal anesthesia was delivered through a 26
Gauge needle using a marcaine 0.5% solution as a single
bolus of 15 – 17.5 mg. Lumbar epidural anesthesia was
delivered through an epidural catheter, inserted through a
Tuohy 16 Gauge needle in the lumbar region. Bupivacaine
0.5% (maximum dose of 2 mg/kg) was given after a test
dose of three ml lidocaine 2% with epinephrine 1:200,000.
When necessary, additional doses of bupivacaine through
the epidural catheter were administered. Drugs used to
treat hypo- or hypertension were similar to those used for
patients undergoing GA. Pain occurring during or shortly
after inflation of the endovascular moulding balloon, was
treated with IV fentanyl 50 – 150 g. When indicated
sedation with midazolam 0.05 – 0.2 mg/kg IV or propofol
25 – 75 g/kg/min IV continuous infusion, was used.
